Feb 13, 2017 · Can stem cells help improve heart muscle in patients with congestive heart failure? The use of stem cells in the treatment of heart failure cases is currently being investigated. Cardiovascular disease is the # 1 killer in the United States accounting for one third of all deaths.5/5(334). Adult Stem Cell Therapy Definitely Helps Congestive Heart Failure Stem cells are unspecialized cells that have two important characteristics that distinguish them from other cells in the body. First, they can replenish their numbers for long periods through cell division.
Stem Cells to Treat Congestive Heart Failure Ischemic Cardiomyopathy (Congestive Heart Failure) Patients Treated with Autologous Angiogenic and Cardio-Regenerative Progenitor Cells Regenocyte provides the best treatments for Cardiomyopathy and Heart failure due to the most advanced stem cell processing and delivery technology. The adult stem cells used to treat heart failure at the Stem Cell Institute come from human umbilical cord tissue (allogeneic mesenchymal). These stem cells are expanded at Medistem Panama’s state-of-the-art laboratory. The mesenchymal stem cells we use are recovered from donated umbilical cords following normal, healthy births.
Apr 21, 2003 · Stem Cells Help Congestive Heart Failure. But that is not the only source of stem cells. The stem cells used in this study were taken from the patients' own bone marrow about four hours before the procedure. Through earlier tests, researchers found that these specific cells have a high probability of becoming blood -vessel and heart cells.Author: Jeanie Lerche Davis. Many conditions can lead to congestive heart failure and cause an individual to need stem cell heart failure therapy. Among the most common are: Heart attacks, especially those associated with coronary artery disease can contribute to heart failure.
CONGESTIVE HEART FAILURE (Adipose derived stem cell treatment) Our process uses adult stem cells, harvested from adipose tissue (fat). We've found that we get a much higher cell yield from adipose tissue, as compared to other sources of adult stem cells, and therefore can reach a therapeutic threshold without the need to culture cells. The partially repaired tissue becomes a burden to the heart, forcing it to work harder and less efficiently, leading to heart failure. Initial research used a patient’s own stem cells, derived from the bone marrow, mainly because they were readily available and had worked in animal studies.
The total number of stem cells residing in the bone marrow of humans at any given time is insufficient for significant organ repair. Bone marrow aspiration, isolation, selection of a specific cell phenotype, and in vitro expansion may be required to achieve sufficient quantities of cells for successful therapy. After institutional review board and government approval, adult autologous stem cell transplantation (CD34+) was performed in patients with ischemic cardiomyopathy and an ejection fraction of less than 35% who were scheduled for primary off-pump coronary artery bypass grafting.Cited by: 334.